Vol. 49 No. 6 (2010): Acta Oncologica

Articles

• A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk

  Ulrika Andersson, Judith Schwartzbaum, Fredrik Wiklund, Sara Sjöström, Yanhong Liu, Spyros Tsavachidis, Anders Ahlbom, Anssi Auvinen, Helle Collatz-Laier, Maria Feychting, Christoffer Johansen, Anne Kiuru, Stefan Lönn, Minouk J. Schoemaker, Anthony J. Swerdlow, Roger Henriksson, Melissa Bondy, Beatrice Melin

  767-775

  Published: 2010-08-01

  • PDF

• LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix

  Håkan Hedman, Annika K. Lindström, Tibor Tot, Ulf Stendahl, Roger Henriksson, Dan Hellberg

  812-815

  Published: 2010-08-01

  • PDF

• Current and predicted cost of metastatic renal cell carcinoma in Finland

  Timo Purmonen, Päivi Nuttunen, Riikka Vuorinen, Seppo Pyrhönen, Vesa Kataja, Pirkko Kellokumpu-Lehtinen

  837-843

  Published: 2010-08-01

  • PDF

• Aneurysm formation in an angiomyolipoma during bevacizumab combination therapy

  Geert Maleux, Johan Vaninbroukx, Sam Heye, Eric van Cutsem, Raymond Oyen

  864-866

  Published: 2010-08-01

  • PDF

• Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping

  Ali Jangjoo, Mohammad Naser Forghani, Mostafa Mehrabibahar, Ramin Sadeghi

  877-878

  Published: 2010-08-01

  • PDF

• Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

  Eva Tiensuu Janson, Halfdan Sørbye, Staffan Welin, Birgitte Federspiel, Henning Grønbæk, Per Hellman, Øystein Mathisen, Jann Mortensen, Anders Sundin, Espen Thiis-Evensen, Matti J. Välimäki, Kjell Öberg, Ulrich Knigge

  740-756

  Published: 2010-08-01

  • PDF

• Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer

  Katarina Öhrling, David Edler, Marja Hallström, Peter Ragnhammar

  797-804

  Published: 2010-08-01

  • PDF

• Sexual function in females after radiotherapy for rectal cancer

  Kjersti Bruheim, Kjell Magne Tveit, Eva Skovlund, Lise Balteskard, Erik Carlsen, Sophie D. Fosså, Marianne G. Guren

  826-832

  Published: 2010-08-01

  • PDF

• Somatic mutation of EXO1 gene in gastric and colorectal cancers with microsatellite instability

  Yoo Ri Kim, Nam Jin Yoo, Sug Hyung Lee

  859-860

  Published: 2010-08-01

  • PDF

• Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor

  Ian M Collins, Peter Beddy, Kenneth J O'Byrne

  872-874

  Published: 2010-08-01

  • PDF

• Patterns of care for European colorectal cancer patients diagnosed 1996–1998: A EUROCARE High Resolution Study

  Gemma Gatta, Giulia Zigon, Tiiu Aareleid, Eva Ardanaz, Magdalena Bielska-Lasota, Jaume Galceran, Stanisław Góźdź, Timo Hakulinen, Carmen Martinez-Garcia, Ivan Plesko, Maja Primic Žakelj, Jadwiga Rachtan, Giovanna Tagliabue, Marina Vercelli, Jean Faivre

  776-783

  Published: 2010-08-01

  • PDF

• Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

  Anthoula Koliadi, Cecilia Nilsson, Marit Holmqvist, Lars Holmberg, Manuel de La Torre, Fredrik Wärnberg, Marie-Louise Fjällskog

  816-820

  Published: 2010-08-01

  • PDF

• Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden

  Ulla Wilking, Bengt Jönsson, Nils Wilking, Jonas Bergh

  844-850

  Published: 2010-08-01

  • PDF

• Scleroderma induced by paclitaxel

  Joanna Vitfell Pedersen, Signe Jensen, Anders Krarup-Hansen, Lene Riis

  866-868

  Published: 2010-08-01

  • PDF

• Barriers to participation in cancer prevention clinical trials

  Michael J. Hall, Brian Egleston, Suzanne M. Miller, Joanne S. Buzaglo, Jennifer Millard, Caroline Ridgway, Nevena Damjanov, John D. Sprandio, Neal J. Meropol

  757-766

  Published: 2010-08-01

  • PDF

• Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients

  Anne Fog Lomholt, Ib J. Christensen, Gunilla Høyer-Hansen, Hans J. Nielsen

  805-811

  Published: 2010-08-01

  • PDF

• Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer

  Camilla Qvortrup, Benny Vittrup Jensen, Trine Lembrecht Jorgensen, Dorte Nielsen, Jon Kroll Bjerregaard, Per Pfeiffer

  833-836

  Published: 2010-08-01

  • PDF

• High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

  In Keun Choi, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo

  861-864

  Published: 2010-08-01

  • PDF

• Death due to liver failure during endocrine therapy for premenopausal breast cancer

  Manuela Rabaglio, Barbara Ruepp

  874-876

  Published: 2010-08-01

  • PDF

• Trends in colorectal cancer in the south of the Netherlands 1975–2007: Rectal cancer survival levels with colon cancer survival

  Valery Lemmens, Liza van Steenbergen, Maryska Janssen-Heijnen, Hendrik Martijn, Harm Rutten, Jan Willem Coebergh

  784-796

  Published: 2010-08-01

  • PDF

• T but not N stage predicts survival for patients with tonsillar carcinoma treated with external radiotherapy and brachytherapy

  Luaay Aziz, Jan Nyman, Staffan Edström

  821-825

  Published: 2010-08-01

  • PDF

• Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib – a Swedish model application

  Ola Ghatnekar, Frida Hjalte, Matthew Taylor

  851-858

  Published: 2010-08-01

  • PDF

• Infarct associated sarcoma: A possible pathogenesis based on histological observation of repair tissue origin in two cases

  Won-Jong Bahk, An-Hi Lee, Yong-Koo Kang, Jung-Mi Park, Yang-Guk Chung, Duck-Sup Shin, Joon-Hyuk Choi

  868-872

  Published: 2010-08-01

  • PDF